I-131-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma


Gedik G. K., Hoefnagel C. A., Bais E., Olmos R. A. V.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.35, no.4, pp.725-733, 2008 (SCI-Expanded) identifier identifier identifier

Abstract

Purpose (131)Iodine metaiodobenzylguanidine (I-131-MIBG) is a radiopharmaceutical used for scintigraphic localisation of phaeochromocytomas and paragangliomas. The experience with its therapeutic use is limited. We report our experience for the treatment of malignant phaeochromocytoma and paraganglioma.